Journal
EXPERT REVIEW OF VACCINES
Volume 15, Issue 11, Pages 1373-1392Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14760584.2016.1179583
Keywords
Staphylococcus aureus; infection; prevention; vaccine; pathophysiology
Categories
Funding
- Pfizer
Ask authors/readers for more resources
Staphylococcus aureus is both a commensal organism and also an important opportunistic human pathogen, causing a variety of community and hospital-associated pathologies, such as bacteremia-sepsis, endocarditis, pneumonia, osteomyelitis, arthritis and skin diseases. The resurgence of S. aureus during the last decade in many settings has been facilitated not only by bacterial antibiotic resistance mechanisms but also by the emergence of new S. aureus clonal types with increased expression of virulence factors and the capacity to neutralize the host immune response. Prevention of the spread of S. aureus infection relies on the use of contact precautions and adequate procedures for infection control that so far have not been fully effective. Prevention using a prophylactic vaccine would complement these processes, having the potential to bring additional, significant progress toward decreasing invasive disease due to S. aureus.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available